STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
TAK TAKEDA PHARMACEUTICAL COMPANY LIMITED StockScouter® Report
5
StockScouter® Score
TAKEDA PHARMACEUTICAL COMPANY LIMITED, a large cap value company in the healthcare sector, is expected to perform in line with the market over the next six months with less than average risk
10 is the best possible rating. Learn more.
Summary
Positives
- The enterprise value-to-sales ratio is lower than the average for comparably-sized companies in the StockScouter universe. Positive
- The ratio of TAK’s forward price-to-earnings multiple to its estimated growth rate is well below the average of comparably-sized companies in the StockScouter universe. Positive
Concerns
- The multi-period measure of relative price change and consistency is below average. Negative/Neutral
- Moving average analysis for TAK suggests downward price movement over the medium term. Negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that large cap stocks will be out of favor, value stocks will be out of favor, and healthcare stocks will be out of favor.
Expected Risk/Return
Core Model Grades
N/A
C
B
D